LivaNova is a global medical technology company that develops innovative devices and therapies for cardiac surgery, cardiopulmonary support, and neuromodulation treatments. The company's primary produ... LivaNova is a global medical technology company that develops innovative devices and therapies for cardiac surgery, cardiopulmonary support, and neuromodulation treatments. The company's primary product portfolio includes vagus nerve stimulation therapy for drug-resistant epilepsy and difficult-to-treat depression, along with advanced cardiopulmonary solutions for cardiac surgical procedures. LivaNova serves healthcare providers and patients worldwide, addressing critical medical needs in neurology and cardiovascular care. Established through the 2015 merger of Cyberonics and Sorin, the company combines decades of expertise in both neuromodulation and cardiopulmonary innovation. Operating through specialized business units headquartered in different regions, LivaNova also maintains a digital health initiative focused on epilepsy treatment support. The company is headquartered in London and employs thousands of professionals dedicated to transforming patient outcomes through advanced medical technology solutions.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

LivaNova is not subject to EU Taxonomy reporting

Based on current regulatory requirements, LivaNova is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review LivaNova's data?

Start your 30-day free trial to request a data review for LivaNova.

Start Free Trial

Legal Center Contact Us

LivaNova PLC

LivaNova is not subject to EU Taxonomy reporting

Account Restricted